181 related articles for article (PubMed ID: 17881527)
1. Involvement of nitric oxide in depolarization-induced suppression of inhibition in hippocampal pyramidal cells during activation of cholinergic receptors.
Makara JK; Katona I; Nyíri G; Németh B; Ledent C; Watanabe M; de Vente J; Freund TF; Hájos N
J Neurosci; 2007 Sep; 27(38):10211-22. PubMed ID: 17881527
[TBL] [Abstract][Full Text] [Related]
2. Functional localization of cannabinoid receptors and endogenous cannabinoid production in distinct neuron populations of the hippocampus.
Hoffman AF; Riegel AC; Lupica CR
Eur J Neurosci; 2003 Aug; 18(3):524-34. PubMed ID: 12911748
[TBL] [Abstract][Full Text] [Related]
3. Presynaptic mGluRs Control the Duration of Endocannabinoid-Mediated DSI.
Colmers PLW; Bains JS
J Neurosci; 2018 Dec; 38(49):10444-10453. PubMed ID: 30355625
[TBL] [Abstract][Full Text] [Related]
4. Control of Inhibition by the Direct Action of Cannabinoids on GABAA Receptors.
Golovko T; Min R; Lozovaya N; Falconer C; Yatsenko N; Tsintsadze T; Tsintsadze V; Ledent C; Harvey RJ; Belelli D; Lambert JJ; Rozov A; Burnashev N
Cereb Cortex; 2015 Sep; 25(9):2440-55. PubMed ID: 24646614
[TBL] [Abstract][Full Text] [Related]
5. Postsynaptic diacylglycerol lipase mediates retrograde endocannabinoid suppression of inhibition in mouse prefrontal cortex.
Yoshino H; Miyamae T; Hansen G; Zambrowicz B; Flynn M; Pedicord D; Blat Y; Westphal RS; Zaczek R; Lewis DA; Gonzalez-Burgos G
J Physiol; 2011 Oct; 589(Pt 20):4857-84. PubMed ID: 21807615
[TBL] [Abstract][Full Text] [Related]
6. Retrograde signaling changes the venue of postsynaptic inhibition in rat substantia nigra.
Yanovsky Y; Mades S; Misgeld U
Neuroscience; 2003; 122(2):317-28. PubMed ID: 14614899
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneous susceptibility of GABA(A) receptor-mediated IPSCs to depolarization-induced suppression of inhibition in rat hippocampus.
Martin LA; Wei DS; Alger BE
J Physiol; 2001 May; 532(Pt 3):685-700. PubMed ID: 11313439
[TBL] [Abstract][Full Text] [Related]
8. Endocannabinoids contribute to metabotropic glutamate receptor-mediated inhibition of GABA release onto hippocampal CA3 pyramidal neurons in an isolated neuron/bouton preparation.
Inada H; Maejima T; Nakahata Y; Yamaguchi J; Nabekura J; Ishibashi H
Neuroscience; 2010 Feb; 165(4):1377-89. PubMed ID: 19961906
[TBL] [Abstract][Full Text] [Related]
9. Cell type-specific regulation of inhibition via cannabinoid type 1 receptors in rat neocortex.
De-May CL; Ali AB
J Neurophysiol; 2013 Jan; 109(1):216-24. PubMed ID: 23054605
[TBL] [Abstract][Full Text] [Related]
10. Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus.
Varma N; Carlson GC; Ledent C; Alger BE
J Neurosci; 2001 Dec; 21(24):RC188. PubMed ID: 11734603
[TBL] [Abstract][Full Text] [Related]
11. Diacylglycerol lipase is not involved in depolarization-induced suppression of inhibition at unitary inhibitory connections in mouse hippocampus.
Min R; Testa-Silva G; Heistek TS; Canto CB; Lodder JC; Bisogno T; Di Marzo V; Brussaard AB; Burnashev N; Mansvelder HD
J Neurosci; 2010 Feb; 30(7):2710-5. PubMed ID: 20164355
[TBL] [Abstract][Full Text] [Related]
12. Calcium dependence of depolarization-induced suppression of inhibition in rat hippocampal CA1 pyramidal neurons.
Lenz RA; Alger BE
J Physiol; 1999 Nov; 521 Pt 1(Pt 1):147-57. PubMed ID: 10562341
[TBL] [Abstract][Full Text] [Related]
13. Lack of depolarization-induced suppression of inhibition (DSI) in layer 2/3 interneurons that receive cannabinoid-sensitive inhibitory inputs.
Lemtiri-Chlieh F; Levine ES
J Neurophysiol; 2007 Nov; 98(5):2517-24. PubMed ID: 17881480
[TBL] [Abstract][Full Text] [Related]
14. Acetylcholine Facilitates a Depolarization-Induced Enhancement of Inhibition in Rat CA1 Pyramidal Neurons.
Domínguez S; Fernández de Sevilla D; Buño W
Cereb Cortex; 2017 Jan; 27(1):852-862. PubMed ID: 26620268
[TBL] [Abstract][Full Text] [Related]
15. Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus.
Kim J; Isokawa M; Ledent C; Alger BE
J Neurosci; 2002 Dec; 22(23):10182-91. PubMed ID: 12451119
[TBL] [Abstract][Full Text] [Related]
16. Evidence for endogenous excitatory amino acids as mediators in DSI of GABA(A)ergic transmission in hippocampal CA1.
Morishita W; Alger BE
J Neurophysiol; 1999 Nov; 82(5):2556-64. PubMed ID: 10561426
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of the group II mGluR agonist, DCG-IV, on depolarization-induced suppression of inhibition in hippocampal CA1 and CA3 neurons.
Morishita W; Alger BE
Hippocampus; 2000; 10(3):261-8. PubMed ID: 10902895
[TBL] [Abstract][Full Text] [Related]
18. Postsynaptic origin of CB1-dependent tonic inhibition of GABA release at cholecystokinin-positive basket cell to pyramidal cell synapses in the CA1 region of the rat hippocampus.
Neu A; Földy C; Soltesz I
J Physiol; 2007 Jan; 578(Pt 1):233-47. PubMed ID: 17053036
[TBL] [Abstract][Full Text] [Related]
19. Endocannabinoid signalling selectively targets perisomatic inhibitory inputs to pyramidal neurones in juvenile mouse neocortex.
Trettel J; Fortin DA; Levine ES
J Physiol; 2004 Apr; 556(Pt 1):95-107. PubMed ID: 14742727
[TBL] [Abstract][Full Text] [Related]
20. Delta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus.
Laaris N; Good CH; Lupica CR
Neuropharmacology; 2010; 59(1-2):121-7. PubMed ID: 20417220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
